Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Merk

Showing results (51-60 of 165) with videos related to

Pageof 17
Sort By:
Medchemcomm|August 29, 2018
Scaffold hopping from synthetic RXR modulators by virtual screening and <i>de novo</i> designDaniel Merk, Francesca Grisoni, Lukas Friedrich, et al.
Chemmedchem|January 18, 2024
Rational design and virtual screening identify mimetics of the RXR agonist valerenic acidLaura Isigkeit, Annette Kärcher, Gustave Adouvi, et al.
Chemmedchem|June 15, 2022
Druggability Evaluation of the Neuron Derived Orphan Receptor (NOR-1) Reveals Inverse NOR-1 AgonistsDaniel Zaienne, Silvia Arifi, Julian A Marschner, et al.
Future Medicinal Chemistry|August 28, 2015
Pirinixic acids: flexible fatty acid mimetics with various biological activitiesDaniel Merk, Martina Zettl, Dieter Steinhilber, et al.
Chemistryopen|October 30, 2019
Synthetic Activators of Cell Migration Designed by Constructive Machine LearningDominique Bruns, Daniel Merk, Karthiga Santhana Kumar, et al.
Pharmacology & Therapeutics|December 3, 2015
Small molecules with anti-inflammatory properties in clinical developmentThomas Hanke, Daniel Merk, Dieter Steinhilber, et al.
Chemmedchem|February 8, 2022
Scaffold Hopping from Amodiaquine to Novel Nurr1 Agonist Chemotypes via Microscale Analogue LibrariesSabine Willems, Marcel Müller, Julia Ohrndorf, et al.
International Journal of Molecular Sciences|October 29, 2020
Chemical Starting Matter for HNF4α Ligand Discovery and ChemogenomicsIsabelle Meijer, Sabine Willems, Xiaomin Ni, et al.
Chemmedchem|May 30, 2019
Computer-Assisted Selective Optimization of Side-Activities-from Cinalukast to a PPARα ModulatorJulius Pollinger, Simone Schierle, Sebastian Neumann, et al.
ACS Pharmacology & Translational Science|April 16, 2021
Differential Therapeutic Effects of FXR Activation, sEH Inhibition, and Dual FXR/sEH Modulation in NASH in Diet-Induced Obese MiceMoritz Helmstädter, Jurema Schmidt, Astrid Kaiser, et al.
Pageof 17

Showing results (51-60 of 165) with videos related to

Sort By:
Pageof 17
Medchemcomm|August 29, 2018
Scaffold hopping from synthetic RXR modulators by virtual screening and <i>de novo</i> designDaniel Merk, Francesca Grisoni, Lukas Friedrich, et al.
Chemmedchem|January 18, 2024
Rational design and virtual screening identify mimetics of the RXR agonist valerenic acidLaura Isigkeit, Annette Kärcher, Gustave Adouvi, et al.
Chemmedchem|June 15, 2022
Druggability Evaluation of the Neuron Derived Orphan Receptor (NOR-1) Reveals Inverse NOR-1 AgonistsDaniel Zaienne, Silvia Arifi, Julian A Marschner, et al.
Future Medicinal Chemistry|August 28, 2015
Pirinixic acids: flexible fatty acid mimetics with various biological activitiesDaniel Merk, Martina Zettl, Dieter Steinhilber, et al.
Chemistryopen|October 30, 2019
Synthetic Activators of Cell Migration Designed by Constructive Machine LearningDominique Bruns, Daniel Merk, Karthiga Santhana Kumar, et al.
Pharmacology & Therapeutics|December 3, 2015
Small molecules with anti-inflammatory properties in clinical developmentThomas Hanke, Daniel Merk, Dieter Steinhilber, et al.
Chemmedchem|February 8, 2022
Scaffold Hopping from Amodiaquine to Novel Nurr1 Agonist Chemotypes via Microscale Analogue LibrariesSabine Willems, Marcel Müller, Julia Ohrndorf, et al.
International Journal of Molecular Sciences|October 29, 2020
Chemical Starting Matter for HNF4α Ligand Discovery and ChemogenomicsIsabelle Meijer, Sabine Willems, Xiaomin Ni, et al.
Chemmedchem|May 30, 2019
Computer-Assisted Selective Optimization of Side-Activities-from Cinalukast to a PPARα ModulatorJulius Pollinger, Simone Schierle, Sebastian Neumann, et al.
ACS Pharmacology & Translational Science|April 16, 2021
Differential Therapeutic Effects of FXR Activation, sEH Inhibition, and Dual FXR/sEH Modulation in NASH in Diet-Induced Obese MiceMoritz Helmstädter, Jurema Schmidt, Astrid Kaiser, et al.
Pageof 17